Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Congresses

Slider Data-Privacy

Congresses Archive

  • Pharmaceuticals

EAACI

2025/06/13-2025/06/16

Glasgow

The EAACI Congress is an eagerly anticipated event within the global community of scientists, healthcare professionals, and stakeholders dedicated to the field of Allergy and Clinical Immunology. It serves as a pivotal platform where scientific community unites to foster collaboration, share knowledge, and collectively advance the understanding of this vital domain. EAACI 2025 will be held in Glasgow where Menarini, as every year, will be present with a booth in the exhibition area and two Symposia.

READ MORE
  • Oncology

EHA

2025/06/12-2025/06/15

Milan, Italy

The European Hematology Association promotes excellence in patient care, research, and education in hematology. They serve medical professionals, researchers, and scientists with an active interest in hematology. They are the largest Europe-based organization with more than 6,000 members from 150 countries, connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology. “Towards prevention, cure, and quality of life for all patients with blood disorders”.

READ MORE
  • Advanced Diagnostics
  • Oncology

ASCO

2025/05/30-2025/06/03

Chicago, Ilinois

Attend the 2025 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care as well as discover state-of-the-art research, groundbreaking treatments, and visionary insights that will ignite your passion for oncology. This year's program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme The Art and Science of Cancer Care: From Comfort to Cure.

READ MORE
  • Diagnostics

EUROMEDLAB

2025/05/18-2025/05/22

Brussels

Euromedlab is the flagship congress for the clinical and diagnostic laboratory community in the global medical arena, organized every two years. This congress not only determines the scientific and clinical directions for medical laboratory practice and diagnosis, but also sets standards for quality and competence. The congress generally covers in vitro diagnostics, laboratory management, quality assurance, and the professional status of laboratory medicine. Euromedlab 2025 will provide a deep understanding and exposure to cutting-edge trends in IVD technologies and diagnosis, with intense participation and interaction from field professional experts. In order to meet the fresh demands, two trends drive the innovative changes in laboratory medicine, enabling the in vitro diagnostics market access to knowledge professionals and patients, and the global market with rapidly expanding potential.

READ MORE
  • Advanced Diagnostics

ESMO Breast

2025/05/14-2025/05/17

Munich, Germany

The ESMO Breast Cancer is a congress organized by the European Society of Medical Oncology, designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It is a multidisciplinary meeting with a global scope, bringing together the community of experts and advocates presenting and discussing the latest ground-breaking developments in breast oncology and forging powerful new partnerships

 

BOOTH-2025__ESMO.jpg

 

Menarini Silicon Biosystems will be attending the ESMO Breast Cancer Congress 2025, an event focused on the latest developments in the science and clinical management of breast cancer.
The congress brings together oncologists, researchers, and healthcare professionals from around the world to share data, clinical experiences, and research findings aimed at improving breast cancer care.
Menarini Silicon Biosystems’s Medical Affairs team will be available at the booth throughout the congress to discuss the role of liquid biopsy technologies in advancing precision oncology for breast cancer.
To arrange a meeting during the congress, please contact us using the following link:

READ MORE

READ MORE
  • Pharmaceuticals

EAS

2025/05/04-2025/05/07

Glasgow

The 93rd European Atherosclerosis Society (EAS) Congress will be held in Glasgow, Scotland from May 4-7, 2025. This congress focuses on atherosclerosis and related vascular diseases, covering the latest research from basic science to clinical trials and its impact on diagnosis and treatment. It's designed for clinicians and basic researchers working in the field. The congress offers a high-level scientific program featuring world-leading experts, including the Anitschkow Lecture, Keynote Lectures, Plenary Sessions, Workshops, and Clinical Seminars. Attendees will have opportunities for networking and collaboration. The EAS is committed to supporting young investigators through fellowships and presentations. The congress will have both in-person and virtual attendance options. It's a major international conference for anyone involved in atherosclerosis research and clinical practice, with a strong emphasis on in-person interaction to drive progress in the field.

READ MORE
  • Pharmaceuticals

ESCMID Global

2025/04/11-2025/04/15

Vienna, Austria

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the leading Society for Clinical Microbiology and Infectious Diseases in Europe. In the wake of the COVID-19 pandemic, ESCMID now plays an important role in emerging infectious diseases and antimicrobial resistance education and research.
Leading experts in infectious diseases and clinical microbiology meet at ESCMID Global to exchange ideas and explore the latest innovations. ESCMID 2025 offers five days packed with keynote lectures, oral sessions, workshops, symposia, meet-the-expert sessions and poster presentations, making it the world’s most eminent event in the field of infection. Participation has been growing year on year with over 18K attendees in 2024.

READ MORE
  • Pharmaceuticals

RPD2025

2025/04/10-2025/04/12

Rome

The Roma Pain Days Congress (RPD25) is a unique event dedicated to pain management, which aims to bring together experts, innovators and professionals in the field, including highly recognized international scientific figures. The goal of the congress is to explore the latest innovations and advanced techniques in pain care. This event offers professionals the opportunity to update their knowledge, enabling them to acquire skills that can improve their clinical practice. The congress will be held in a hybrid format, combining in-person and virtual participation options. In addition to the sponsored sessions, this year's congress will feature "Meet-the-Expert" (MtE) sessions. During these sessions, a faculty member will give a presentation and open a discussion with the participants, allowing for clarification and discussion on pain-related topics. This interactive format will encourage active participation from participants, fostering the dissemination of scientific knowledge in the field. Menarini will be present as main sponsor with a scientific session involving an important board of international experts

READ MORE
  • Diagnostics

EAU25 Europe’s biggest urological event

2025/03/21-2025/03/25

Madrid, Spain

The 40th Annual EAU Congress will be taking place in Madrid in the spring of 2025! Spain's capital will host EAU25, Europe's largest urology event from 21-24 March 2025.With an expected attendance of thousands, the congress will feature a diverse range of participants, including urologists, oncologists, nurses, and allied health professionals.

READ MORE
  • Diagnostics

ATTD

2025/03/19-2025/05/22

Amsterdam

ATTD is the ultimate meeting to discover the latest research, devices and global developments in the field of diabetes. Join us from 19-22 March 2025, in Amsterdam, The Netherlands, for the 18th International Conference on Advanced Technologies and Treatments for Diabetes. ATTD 2025 will also emphasise the importance of patient involvement in diabetes management. Discussions will focus on how technology can enable patients to take control of their health, leading to better outcomes. By involving patients in the conversation, the conference aims to emphasise the need for user-friendly technologies that meet the diverse needs of people living with diabetes.

READ MORE
  • Diagnostics

Non-Muscle Invasive Bladder Cancer (NMIBC) Masterclass

2025/02/27-2025/02/28

Prague, Czech Republic

The Non-Muscle Invasive Bladder Cancer Masterclass represents a unique opportunity to deepen your expertise and stay abreast of the latest advancements in the field. With a robust agenda focused on practical application and real-world implications, participants will leave equipped with new tools and perspectives to enhance their approach to NMIBC. At this masterclass will attend urologists, oncologists, pathologists, nurses, and researchers engaged in the treatment and study of bladder cancer.

READ MORE

Select a Year from the Archive